TB Alliance manages the largest pipeline of new TB drugs in history.
The head of External Affairs will lead, strategically and operationally, a broad, multi-faceted resource generation program to enable the TB Alliance to achieve its goals. The head of External Affairs is responsible for providing strategic leadership to the TB Alliance's fundraising, advocacy, policy, community and stakeholder engagement, and communications functions, and has direct oversight for mobilizing resources, advocating for supportive public policies and funding, and engaging stakeholders and communities.
This individual will be knowledgeable about a wide range of funding sources across the public and private sectors. She or he will be well-versed in the public health policy-making process and will conceptualize and implement plans to influence decision-making and advocacy in support of resource mobilization. The incumbent will be responsible for representing the TB Alliance externally and building strong relationships with key stakeholders and will have responsibility for managing the TB Alliance Stakeholders Association (SHA). This individual will also manage the Communications team to ensure that the TB Alliance communicates strategically with current and prospective funders, the media, and other constituencies.
A strong candidate must have or develop broad understanding of the organization's activities in research and development (R&D) and market access. The head of External Affairs must be able to effectively optimize both traditional and novel resource generation channels including but not limited to:
Oversee resource generation, grant management and donor relations
Lead development and implementation of advocacy strategies to influence health policy and generate political and financial commitments for TB drug regimen development and product introduction.
Apply policy research to build the evidence base for policy recommendations and support resource mobilization efforts
. Foster a collaborative network of stakeholders and communities
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.Through innovative science and with partners around the globe, we lead a global effort to ensure development of and equitable access to faster, better tuberculosis cures that will advance global health and prosperity.
With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website: www.tballiance.org.